American Society of Hematology

SHERPA: Blue

People

  1. Abdel-Wahab
    Abdel-Wahab
  2. Levine
    Levine
  3. Intlekofer
    Intlekofer
  4. Rampal
    Rampal
  5. Thompson
    Thompson
  6. Armstrong
    Armstrong
  7. Bhagwat
    Bhagwat
  8. Chiosis
    Chiosis
  9. Dogan
    Dogan
  10. Knapp
    Knapp

Groups

  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Executive Committee, Center for Hematologic Malignancies (11)
  4. GSK Faculty (11)
  5. Hematologic Malignancies Research (11)
  6. Hematologic Malignancies, Division of (11)
  7. Human Oncology and Pathogenesis Program (11)
  8. Tow Center for Developmental Oncology (TCDO) (11)
  9. Adult Leukemia (9)
  10. Sloan Kettering Institute Faculty (8)
Search Within
  1. "Meeting abstract"
  2. "Human Oncology and Pathogenesis Program"
  3. "Omar Abdel-Wahab"
  4. "Hematologic Malignancies Research"
Formats
  1. Meeting Abstract (11)
Groups
  1. Center for Hematologic Malignancies (11)
  2. Department of Medicine (11)
  3. Executive Committee, Center for Hematologic Malignancies (11)
  4. GSK Faculty (11)
  5. Hematologic Malignancies Research (11)
  6. Hematologic Malignancies, Division of (11)

More Groups

People
  1. Omar Abdel-Wahab (11)
  2. Ross Levine (9)
  3. Andrew Intlekofer (5)
  4. Craig Thompson (3)
  5. Raajit Rampal (3)
  6. Ahmet Dogan (2)

More People

Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2017 (2)
  4. 2014 (2)
  5. 2013 (2)
  6. 2011 (2)

More Years

Publications
  1. Blood (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1b multi-center study of the FLT3 inhibitor gilteritinib in combination with the IDH1 inhibitor ivosidenib or the IDH2 inhibitor enasidenib for patients with relapsed or refractory acute myeloid leukemia who have co-occurring FLT3/IDH1 or FLT3/IDH2 mutations
    Meeting Abstract

    Stein, E. M.; Derkach, A.; Melamed, G.; Block, A.; Kim, J.; Georgieva, G.; Thompson, V.; Levine, R. L.; Intlekofer, A. M.; Abdel-Wahab, O.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Immune escape after allogeneic hematopoietic cell transplantation in pediatric patients with acute myeloid leukemia
    Meeting Abstract

    Shahid, S.; Ceglia, N.; Le Luduec, J. B.; McPherson, A.; Spitzer, B.; Bojilova, V.; Panjwani, M. K.; Roshal, M.; Shah, S.; Abdel-Wahab, O.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Spliceosomal dysfunction Is a critical mediator of IDH2 mutant leukemogenesis
    Meeting Abstract

    Yoshimi, A.; Lin, K. T.; Wiseman, D.; Intlekofer, A. M.; Wang, B.; Pastore, A.; Rahman, M.; Lee, S. C. W.; Liu, B.; Micol, J. B.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Comprehensive genomic profiling (CGP) informs molecular diagnosis, prognosis, and therapeutic decision-making for patients with angioimmunoblastic T-cell lymphoma (AITL)
    Meeting Abstract

    Morley, S.; He, J.; Intlekofer, A. M.; Bailey, M.; Nahas, M.; Heilmann, A.; Chudnovsky, Y.; Fabrizio, D.; Ali, S. M.; Lipson, D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid lukemia
    Meeting Abstract

    Rampal, R. K.; Alkalin, A.; Madzo, J.; Vasanthakumar, A.; Pronier, E.; Patel, J. P.; Li, Y. S.; Ahn, J.; Abdel-Wahab, O.; Shih, A. H.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical utility of comprehensive profiling of genomic alterations in hematologic malignancies
    Meeting Abstract

    He, J.; Bufill, J. A.; Nahas, M. K.; Wang, K.; Young, L. E.; Knapp, K. M.; Brennan, K. W.; Donahue, A. L.; Young, G.; Ross, J. S.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Arginine methylation of RBM15 by PRMT1 controls alternative splicing of genes involved in megakaryocyte differentiation
    Meeting Abstract

    Zhao, X.; Zhang, L.; Wang, R.; Trans, N. T.; Su, H.; Abdel-Wahab, O.; Hrick, T.; Levine, R. L.; Deng, H.; Liu, Y.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Identification of actionable genomic alterations in hematologic malignancies by a clinical next generation sequencing-based assay
    Meeting Abstract

    Lipson, D.; Nahas, M. K.; Otto, G. A.; Yelensky, R.; Abdel-Wahab, O.; Wang, K.; He, J.; Intlekofer, A. M.; Rampal, R. K.; Brennan, T. A.; more...
    Blood (2013)

    Fulltext@MSK | Save
  • Epigenetic effects of IDH1/IDH2 mutations
    Meeting Abstract

    Melnick, A. M.; Levine, R. L.; Figueroa, M. E.; Thompson, C. B.; Abdel-Wahab, O.
    Blood (2011)

    Fulltext@MSK | Save
  • Heterodimeric JAK-STAT activation as a mechanism of persistence to JAK2 inhibitor therapy
    Meeting Abstract

    Bhagwat, N.; Koppikar, P.; Kilpivaara, O.; Manshouri, T.; Adli, M.; Mullally, A.; Abdel-Wahab, O.; Leung, L.; Weinstein, A.; Marubayashi, S.; more...
    Blood (2011)

    Fulltext@MSK | Save